NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Total Current Liabilities

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) (NRSNW) currently reports a total current liabilities of $2.5M as of December 2025. That compares with $2M in the prior-year period — up 26.3% year over year. Use the charts on this page to explore NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s total current liabilities history and peer comparisons.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s total current liabilities increased from $2M to $2.5M — a 26.3% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) reported $2.5M in total current liabilities as of December 2025. That compares with $2M in the prior-year period — up 26.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $2.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroSense Therapeutics Ltd - Warrants (09/11/2026), and consider following NRSNW for alerts when major investors trade the stock.